The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Cytokines and their relationship to the symptoms and outcome of cancer
Open accessAbstract
Tumours contain immune cells and a network of pro- and anti-inflammatory cytokines, which collaborate in the development and progression of cancer. Cytokine profiles might prove to be prognostic. The systemic effects of pro-inflammatory cytokines are associated with fatigue, depression and cognitive impairment, and can affect quality of life before, during and after treatment. In people with advanced cancer, pro-inflammatory cytokines are additionally associated with anorexia and cachexia, pain, toxicity of treatment and resistance to treatment. However, physical activity might modify cytokine levels and decrease fatigue in patients with cancer, and might also improve their prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The treatment of physical disorders, e.g., interferon-based or virostatic treatments for hepatitis C (167, 197), chemotherapy for the treatment of cancer (168), surgery (169) or transplantation (170), can lead to additional cytokine release.”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [168]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. M. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,166
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,603
Flagged first, then by citations
Cited by
Sorted by citations
Cancer-related fatigue—mechanisms, risk factors, and treatments
Bower, J. E. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.127 · Cited by 1,666
Depression as a predictor of disease progression and mortality in cancer patients: A Meta‐Analysis
Satin, J. R., Linden, W., & Phillips, M. J. (2009) · Cancer · doi:10.1002/cncr.24561 · Cited by 972
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 975
Cuijpers, P., Vogelzangs, N., Twisk, J., Kleiboer, A., Li, J., & Penninx, B. W. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030325 · Cited by 677
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 671
Role of Inflammation in Muscle Homeostasis and Myogenesis
Costamagna, D., Costelli, P., Sampaolesi, M., & Penna, F. (2015) · Mediators of Inflammation · doi:10.1155/2015/805172 · Cited by 547
Cancer-associated venous thromboembolism: Burden, mechanisms, and management
Ay, C., Pabinger, I., & Cohen, A. T. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-08-0615 · Cited by 501
Bonetto, A., Aydogdu, T., Jin, X., Zhang, Z., Zhan, R., Puzis, L., Koniaris, L. G., & Zimmers, T. A. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00039.2012 · Cited by 463
Bendinelli, P., Matteucci, E., Dogliotti, G., Romanelli, M. M. C., Banfi, G., Maroni, P., & Desiderio, M. A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22274 · Cited by 461
Brown, D. W., Anda, R. F., Felitti, V. J., Edwards, V. J., Malarcher, A. M., Croft, J. B., & Giles, W. H. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-20 · Cited by 391
Bower, J. E., & Lamkin, D. M. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.06.011 · Cited by 381
Arrieta, O. G., Angulo, L., Núñez-Valencia, C., Dorantes-Gallareta, Y., Macedo, E. O., Martínez-López, D. M., Alvarado, S., Corona-Cruz, J. F., & Oñate-Ocaña, L. F. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2793-5 · Cited by 345
Tumor-Host Interactions: A Far-Reaching Relationship
McAllister, S. S., & Weinberg, R. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4257 · Cited by 333
Inflammation and colorectal cancer
Kraus, S. R., & Arber, N. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.006 · Cited by 323
Kesler, S. R., Janelsins, M. C., Koovakkattu, D., Palesh, O. G., Mustian, K. M., Morrow, G. R., & Dhabhar, F. S. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.017 · Cited by 314
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313
Williams‐Gray, C. H., Wijeyekoon, R., Yarnall, A. J., Lawson, R. A., Breen, D. P., Evans, J., Cummins, G. A., Duncan, G. W., Khoo, T. K., Burn, D. J., et al. (2016) · Movement Disorders · doi:10.1002/mds.26563 · Cited by 310
Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research
Seigers, R., & Fardell, J. E. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.09.006 · Cited by 269
Buffart, L. M., Galvao, D. A., Brug, J., Chinapaw, M. J. M., & Newton, R. U. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.06.007 · Cited by 268
Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment
Pachman, D. R., Barton, D. L., Watson, J. C., & Loprinzi, C. L. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.115 · Cited by 265
Psychological interventions for women with metastatic breast cancer
Mustafa, M., Carson-Stevens, A., Gillespie, D., & Edwards, A. G. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004253.pub4 · Cited by 244
Luo, W. (2023) · Theranostics · doi:10.7150/thno.82690 · Cited by 242
Schellhammer, P. F., Chodak, G. W., Whitmore, J. B., Sims, R. B., Frohlich, M. W., & Kantoff, P. W. (2013) · Urology · doi:10.1016/j.urology.2013.01.061 · Cited by 245
Khosravi, N., Stoner, L. R., Farajivafa, V., & Hanson, E. D. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.08.187 · Cited by 240
Ganz, P. A., Kwan, L. C., Castellon, S. A., Oppenheim, A., Bower, J. E., Silverman, D. H. S., Cole, S. W., Irwin, M. R., Ancoli‐Israel, S., & Belin, T. R. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt073 · Cited by 221
Cognitive Dysfunction in ICU Patients: Risk Factors, Predictors, and Rehabilitation Interventions
Wilcox, M. E., Brummel, N. E., Archer, K., Ely, E. W., Jackson, J. C., & Hopkins, R. O. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182a16946 · Cited by 215
Oh, B., Butow, P. N., Mullan, B. A., Clarke, S. J., Beale, P. J., Pavlakis, N., Lee, M. S., Rosenthal, D. S., Larkey, L., & Vardy, J. L. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1209-6 · Cited by 207
I’m so tired: biological and genetic mechanisms of cancer-related fatigue
Barsevick, A. M., Frost, M. H., Zwinderman, A. H., Hall, P. N., & Halyard, M. Y. (2010) · Quality of Life Research · doi:10.1007/s11136-010-9757-7 · Cited by 201
Kanai, M., Otsuka, Y., Otsuka, K., Sato, M., Nishimura, T., Mori, Y., Kawaguchi, M., Hatano, E., Kodama, Y., Matsumoto, S., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2151-8 · Cited by 201
Cytokines in cancer drug resistance: Cues to new therapeutic strategies
Jones, V. S., Huang, R.-Y., Chen, L.-P., Chen, Z., Fu, L., & Huang, R.-P. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.03.005 · Cited by 199
Targeting Breast Cancer Stem Cells
Zhang, L., Chen, W., Liu, S., & Chen, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.76187 · Cited by 196
Chemobrain: A systematic review of structural and functional neuroimaging studies
Simó, M., Rifà‐Ros, X., Rodríguez‐Fornells, A., & Bruna, J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.015 · Cited by 203
Effects of Chemotherapy on the Immune System: Implications for Cancer Treatment and Patient Outcomes
Sharma, A., Jasrotia, S., & Kumar, A. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02781-2 · Cited by 190
Illi, J., Miaskowski, C. A., Cooper, B. A., Levine, J. D., Dunn, L. B., West, C. M., Dodd, M. J., Dhruva, A., Paul, S. M., Baggott, C., et al. (2012) · Cytokine · doi:10.1016/j.cyto.2012.02.015 · Cited by 190
Inflammatory biomarkers in osteoarthritis
Daghestani, H. N., & Kraus, V. B. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.02.009 · Cited by 181
Cheung, Y. T., & Krull, K. R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.03.016 · Cited by 187
Wen, Z., Liu, H., Gao, R., Zhou, M., Ma, J., Zhang, Y., Zhao, J., Chen, Y., Zhang, T., Huang, F., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0452-5 · Cited by 180
Sleep disturbance, inflammation and depression risk in cancer survivors
Irwin, M. R., Olmstead, R. E., Ganz, P. A., & Haque, R. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.002 · Cited by 173
Deegan, C. A., Murray, D. J., Doran, P., Moriarty, D. C., Sessler, D. I., Mascha, E., Kavanagh, B. P., & Buggy, D. J. (2010) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0b013e3181ef4d05 · Cited by 172
Head and Neck Cancer Survivorship: Learning the Needs, Meeting the Needs
Ringash, J. G., Bernstein, L. J., Devins, G. M., Dunphy, C., Giuliani, M., Martino, R., & McEwen, S. E. (2017) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2017.08.008 · Cited by 168
Self-citationCancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem
Tsoli, M., & Robertson, G. R. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.10.006 · Cited by 167
Doong, S.-H., Dhruva, A., Dunn, L. B., West, C. M., Paul, S. M., Cooper, B. A., Elboim, C., Abrams, G., Merriman, J. D., Langford, D. J., et al. (2014) · Biological Research For Nursing · doi:10.1177/1099800414550394 · Cited by 170
Chronotherapy and the molecular clock: Clinical implications in oncology☆
Innominato, P. F., Lévi, F., & Bjarnason, G. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.06.002 · Cited by 168
Morris, G., Berk, M., Gałecki, P., Walder, K. R., & Maes, M. H. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9090-9 · Cited by 163
Palesh, O. G., Peppone, Innominato, Janelsins, Jeong, M., Sprod, L. K., Savard, J., Rotatori, R. M., Telli, Mustian, et al. (2012) · Nature and Science of Sleep · doi:10.2147/nss.s18895 · Cited by 167
Recommendations for High-Priority Research on Cancer-Related Fatigue in Children and Adults
Barsevick, A. M., Irwin, M. R., Hinds, P. S., Miller, A. H., Berger, A. M., Jacobsen, P. B., Ancoli‐Israel, S., Reeve, B. B., Mustian, K. M., O’Mara, A. M., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt242 · Cited by 167
Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
Stockstill, K., Doyle, T. M., Yan, X., Chen, Z., Janes, K., Little, J. W., Braden, K., Lauro, F., Giancotti, L. A., Harada, C. M., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20170584 · Cited by 155
Campello, E., Ilich, A., Simioni, P., & Key, N. S. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0510-x · Cited by 154
Nerve Growth Factor Links Oral Cancer Progression, Pain, and Cachexia
Ye, Y., Dang, D., Zhang, J., Viet, C. T., Lam, D. K., Dolan, J. C., Gibbs, J. L., & Schmidt, B. L. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0123 · Cited by 150
Laviano, A., Rianda, S., Molfino, A., & Fanelli, F. R. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32835d2d99 · Cited by 149
Sprod, L. K., Janelsins, M. C., Palesh, O. G., Carroll, J. K., Heckler, C. E., Peppone, L. J., Mohile, S. G., Morrow, G. R., & Mustian, K. M. (2011) · Journal of Cancer Survivorship · doi:10.1007/s11764-011-0205-7 · Cited by 148
High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer
Silva, E. M., Mariano, V. S., Pastrez, P. R. A., Pinto, M. C., Castro, A. G., Syrjänen, K. J., & Longatto‐Filho, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181125 · Cited by 148
Golubnitschaja, O., Debald, M., Yeghiazaryan, K., Kuhn, W. C., Pešta, M., Costigliola, V., & Grech, G. (2016) · Tumor Biology · doi:10.1007/s13277-016-5168-x · Cited by 147
Kwekkeboom, K. L., Tostrud, L. J., Costanzo, E. S., Coe, C. L., Serlin, R. C., Ward, S. E., & Zhang, Y. (2018) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2018.01.008 · Cited by 147
Gupta, S. C., Kim, J. H., Kannappan, R., Reuter, S., Dougherty, P. M., & Aggarwal, B. B. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011028 · Cited by 146
Leaky brain in neurological and psychiatric disorders: Drivers and consequences
Morris, G., Fernandes, B. S., Puri, B. K., Walker, A. J., Carvalho, A. F., & Berk, M. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418796955 · Cited by 144
van der Willik, K. D., Koppelmans, V., Hauptmann, M., Compter, A., Ikram, M. A., & Schagen, S. B. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1062-3 · Cited by 142
Measures of Cognitive Function and Work in Occupationally Active Breast Cancer Survivors
Calvio, L. C., Peugeot, M., Bruns, G. L., Todd, B. L., & Feuerstein, M. (2010) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3181d0bef7 · Cited by 138
Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis
Mounier, N. M., Abdel-Maged, A. E.-S., Wahdan, S. A., Gad, A. M., & Azab, S. S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118071 · Cited by 139
Innominato, P. F., Giacchetti, S., Bjarnason, G. A., Focan, C., Garufi, C., Coudert, B. P., Iacobelli, S., Tampellini, M., Durando, X., Mormont, M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27574 · Cited by 129
Role of Pro-inflammatory Cytokines in Regulation of Skeletal Muscle Metabolism: A Systematic Review
Sharma, B., & Dabur, R. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867326666181129095309 · Cited by 129
Depression as a Risk Factor for Cancer: From Pathophysiological Advances to Treatment Implications
Currier, M. B., & Nemeroff, C. B. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-061212-171507 · Cited by 126
Siddiqui, J. A., Pothuraju, R., Jain, M., Batra, S. K., & Nasser, M. W. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188359 · Cited by 126
Jones, S. B., Thomas, G. A., Hesselsweet, S. D., Alvarez-Reeves, M., Yu, H., & Irwin, M. L. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0278 · Cited by 132
Review of mifamurtide in the treatment of patients with osteosarcoma
Kager, L., Pötschger, U., & Bielack (2010) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s5688 · Cited by 124
Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development
Geyer, H. L., Dueck, A. C., Scherber, R. M., & Mesa, R. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/284706 · Cited by 124
Paulsen, Ø., Laird, B. J. A., Aass, N., Lea, T., Fayers, P. M., Kaasa, S., & Klepstad, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177620 · Cited by 124
Capozzi, L., McNeely, M. L., Lau, H., Reimer, R. A., Giese‐Davis, J., Fung, T. S., & Culos-Reed, S. N. (2016) · Cancer · doi:10.1002/cncr.29863 · Cited by 123
Vacchelli, E., Galluzzi, L., Eggermont, A. M. M., Galon, J., Tartour, É., Zitvogel, L., & Kroemer, G. (2012) · OncoImmunology · doi:10.4161/onci.20459 · Cited by 122
Seigers, R., Timmermans, J., van der Horn, H. J., de Vries, E. F. J., Dierckx, R., Visser, L., Schagen, S. B., van Dam, F. S. A. M., Koolhaas, J. M., & Buwalda, B. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.10.009 · Cited by 119
Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer
Patel, S. K., Wong, A. L., Wong, F. L., Breen, E. C., Hurria, A., Smith, M., Kinjo, C., Paz, I. B., Kruper, L. L., Somlo, G., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv131 · Cited by 121
N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications
Luo, J., Xu, T., & Sun, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.670711 · Cited by 117
Yamada, T., Takeuchi, S., Nakade, J., Kita, K., Nakagawa, T., Nanjo, S., Nakamura, T., Matsumoto, K., Soda, M., Mano, H., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2972 · Cited by 119
Pretreatment Cancer-Related Cognitive Impairment—Mechanisms and Outlook
Olson, B. G., & Marks, D. L. (2019) · Cancers · doi:10.3390/cancers11050687 · Cited by 122
Crosstalk between the microbiome and cancer cells by quorum sensing peptides
Wynendaele, E., Verbeke, F., D’Hondt, M., Hendrix, A., de Wiele, C. V., Burvenich, C., Peremans, K. Y., Wever, O. D., Bracke, M., & Spiegeleer, B. M. J. D. (2015) · Peptides · doi:10.1016/j.peptides.2014.12.009 · Cited by 116
Qian, D. Z., Rademacher, B. L. S., Pittsenbarger, J., Huang, C., Myrthue, A., Higano, C. S., Garzotto, M. G., Nelson, P. S., & Beer, T. M. (2009) · The Prostate · doi:10.1002/pros.21077 · Cited by 114
Ferriolli, E., Skipworth, R. J. E., Hendry, P. O., Scott, A., Stensteth, J., Dahele, M. R., Wall, L. R., Greig, C. A., Fallon, M., Strasser, F., et al. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.06.013 · Cited by 113
Ormstad, H., Aass, H. C. D., Amthor, K.-F., Lund-Sørensen, N., & Sandvik, L. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5962-8 · Cited by 107
Chuang, C.-M., Monie, A., Wu, A. A., Mao, C.-P., & Hung, C. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.124 · Cited by 107
Lee, D. J., Lee, H. J., Farmer, J. R., & Reynolds, K. L. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01530-2 · Cited by 104
Leeuw, I. M. V., Buffart, L. M., Heymans, M. W., Rietveld, D. H. F., Doornaert, P., de Bree, R., Buter, J., Aaronson, N. K., Slotman, B. J., Leemans, C. R., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.01.002 · Cited by 102
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development
Rao, P. P. N., Kabir, S. N., & Mohamed, T. (2010) · Pharmaceuticals · doi:10.3390/ph3051530 · Cited by 102
Zunini, R. A. L., Scherling, C., Wallis, N., Collins, B., MacKenzie, J., Bielajew, C. H., & Smith, A. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-012-9213-0 · Cited by 101
Banerjee, S., Lin, C.-F. L., Skinner, K. A., Schiffhauer, L. M., Peacock, J. W., Hicks, D. G., Redmond, E. M., Morrow, D. J., Huston, A. J., Shayne, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1778 · Cited by 110
Mykkänen, O. T., Huotari, A., Herzig, K., Dunlop, T. W., Mykkänen, H. M., & Kirjavainen, P. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114790 · Cited by 100
Fatigue in Parkinson’s disease: report from a multidisciplinary symposium
Friedman, J. H., Beck, J. C., Chou, K. L., Clark, G., Fagundes, C. P., Goetz, C. G., Herlofson, K., Kluger, B. M., Krupp, L., Lang, A. E., et al. (2016) · npj Parkinson s Disease · doi:10.1038/npjparkd.2015.25 · Cited by 100
Chen, C.-C., Pekow, J. R., Lladó, V., Kanneganti, M., Lau, C. W., Mizoguchi, A., Mino-Kenudson, M. A., Bissonnette, M., & Mizoguchi, E. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.038 · Cited by 104
Chemotherapy and Cognitive Impairment: Treatment Options
Fardell, J. E., Vardy, J. L., Johnston, I. N., & Winocur, G. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.112 · Cited by 97
Body Composition, Symptoms, and Survival in Advanced Cancer Patients Referred to a Phase I Service
Parsons, H. A., Baracos, V. E., Dhillon, N., Hong, D. S., & Kurzrock, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029330 · Cited by 96
Helicobacter pylori ‐induced miR‐135b‐5p promotes cisplatin resistance in gastric cancer
Shao, L., Chen, Z., Soutto, M., Zhu, S., Lu, H., Romero–Gallo, J., Peek, R. M., Zhang, S., & El-Rifai, W. M. (2018) · The FASEB Journal · doi:10.1096/fj.201701456rr · Cited by 92
Cognitive Functioning After Radiotherapy or Chemoradiotherapy for Head-and-Neck Cancer
Gan, H. K., Bernstein, L. J., Brown, J. I., Ringash, J. G., Vakilha, M., Wang, L. E., Goldstein, D. P., Kim, J., Hope, A. J., O’Sullivan, B., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.05.004 · Cited by 92
Self-citationMcCann, B., Miaskowski, C. A., Koetters, T., Baggott, C., West, C. M., Levine, J. D., Elboim, C., Abrams, G., Hamolsky, D., Dunn, L. B., et al. (2012) · Journal of Pain · doi:10.1016/j.jpain.2011.02.358 · Cited by 91
Ghosh, D., Khajanchi, S., Mangiarotti, S., Denis, F., Dana, S. K., & Christophe Letellier, A. (2017) · Biosystems · doi:10.1016/j.biosystems.2017.05.001 · Cited by 92
Ellis, J. (2014) · Veterinary Pathology · doi:10.1177/0300985814521245 · Cited by 91
Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology.
Guggenheim, A. G., Wright, K. M., & Zwickey, H. L. (2014) · PubMed Central · Cited by 90
Marceca, G. P., Londhe, P., & Calore, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00298 · Cited by 92
Kim, S., Miller, B. J., Stefanek, M. E., & Miller, A. H. (2015) · Cancer · doi:10.1002/cncr.29302 · Cited by 93
Systemic immune-inflammation index in germ-cell tumours
Chovanec, M., Cierna, Z., Miskovska, V., Machalekova, K., Kalavska, K., Rejlekova, K., Svetlovska, D., Macak, D., Spanik, S., Kajo, K., et al. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.460 · Cited by 90
Postdiagnosis C-Reactive Protein and Breast Cancer Survivorship: Findings from the WHEL Study
Villaseñor, A., Flatt, S. W., Marinac, C., Natarajan, L., Pierce, J. P., & Patterson, R. E. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0852 · Cited by 89
Systematic Review and Meta-Analysis on the Association between IL-1B Polymorphisms and Cancer Risk
Xu, J., Yin, Z., Cao, S., Gao, W., Liu, L., Yin, Y., Liu, P., & Shu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063654 · Cited by 89
Metadata
- Authors
- Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F.
- Affiliations
- St. Michael's Hospital (CA)
- Corresponding author
- Tannock, Ian F.
- Venue
- Nature Reviews Cancer
- Published
- 2008-10-10
- Volume
- 8
- Issue
- 11
- Pages
- 887-899
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2061366514
- Cited by
- 652
- References
- 248
- Citations by year
- 2026: 11 · 2025: 23 · 2024: 35 · 2023: 26 · 2022: 37 · 2021: 47 · 2020: 33 · 2019: 33 · 2018: 45 · 2017: 33 · 2016: 48 · 2015: 41 · 2014: 45 · 2013: 45 · 2012: 60
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- inflammatory cytokines, advanced cancer, cancer-related fatigue, cancer cachexia, anorexia, cancer pain, depression, cognitive impairment, treatment toxicity, treatment resistance, tumor immune microenvironment, quality of life, physical activity, cytokine signaling pathways
- MeSH terms
- Anorexia, Cachexia, Depressive Disorder, Humans, Neoplasms, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review